ASEM 문헌 요약
Official Canadian Paediatric Society document (2024) on “Respiratory syncytial virus (RSV) prevention strategies for the 2024-2025 viral respiratory illness season”. Prevention of respiratory syncytial virus (RSV) infection in young children, particularly those at highest risk of severe illness, is an important public health goal. Previously, palivuzimab was the only preventative agent available in Canada but recently, two new agents have been approved for use. This paper provides a brief review of the National Advisory Committee on Immunization (NACI)’s latest recommendations fo.
이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.
공식 문서